Medipharm Labs Corp
TSX:LABS
Medipharm Labs Corp
Income from Continuing Operations
Medipharm Labs Corp
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medipharm Labs Corp
TSX:LABS
|
Income from Continuing Operations
-CA$7.5m
|
CAGR 3-Years
46%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Canopy Growth Corp
TSX:WEED
|
Income from Continuing Operations
-CA$604.1m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
15%
|
CAGR 10-Years
-72%
|
|
|
Sundial Growers Inc
NASDAQ:SNDL
|
Income from Continuing Operations
-CA$106.3m
|
CAGR 3-Years
7%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Income from Continuing Operations
$50.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-44%
|
CAGR 10-Years
N/A
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Income from Continuing Operations
CA$11.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
27%
|
CAGR 10-Years
-22%
|
|
|
Cipher Pharmaceuticals Inc
TSX:CPH
|
Income from Continuing Operations
$9.2m
|
CAGR 3-Years
3%
|
CAGR 5-Years
16%
|
CAGR 10-Years
-6%
|
|
Medipharm Labs Corp
Glance View
MediPharm Labs Corp. is medicinal cannabis company, which engages in the pharmaceutical grade production of cannabis oil products. The company is headquartered in Barrie, Ontario and currently employs 190 full-time employees. The company went IPO on 2018-02-09. The firm produces purified, pharmaceutical-like cannabis extracts and related derivative products. The firm formulates, processes, packages and distributes cannabis extracts and cannabinoid-based products at its Canadian and Australian facilities for domestic and international markets. The Company, through its subsidiaries is engaged in the sale and distribution of cannabis oil, cannabis extracts, cannabis edibles, cannabis topicals, and derivatives to authorized classes of purchasers, as well as controlled human administration trials for sensory testing of cannabis extracts and derivative products. The company is also engaged in the manufacturing of extracts and tinctures of cannabis and cannabis resin for the purpose of a clinical trial or prescribed as medical cannabis products. The firm's wholly owned subsidiaries include MediPharm Labs Inc. and MediPharm Labs Australia Pty. Ltd.
See Also
What is Medipharm Labs Corp's Income from Continuing Operations?
Income from Continuing Operations
-7.5m
CAD
Based on the financial report for Mar 31, 2025, Medipharm Labs Corp's Income from Continuing Operations amounts to -7.5m CAD.
What is Medipharm Labs Corp's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
14%
Over the last year, the Income from Continuing Operations growth was 45%. The average annual Income from Continuing Operations growth rates for Medipharm Labs Corp have been 46% over the past three years , 14% over the past five years .
You don't have any saved screeners yet